Proposal of new classification for postoperative patients with hepatocellular carcinoma based on tumor growth characteristics

doi:10.3748/wjg.v19.i33.5534

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 33

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6148)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

366

HTML

3412

Figures (1-4)

285

Tables (1-4)

237

Sum=4300

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

975

Download

873

Sum=1848

Sep 7, 2013 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 7, 2013; 19(33): 5534-5541
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5534

Table 1 Patients and tumor characteristics n (%)

Characteristics	n = 288
Age (yr)
≤ 60	208 (72.2)
> 60	80 (27.8)
Gender
Female	49 (17.0)
Male	239 (83.0)
HBV infection	211 (75.36)
TNM stage
I	119 (41.3)
II	22 (7.6)
IIIA	24 (8.3)
IIIB	25 (8.7)
IIIC	66 (22.9)
IVA	21 (7.3)
IVB	11 (3.8)
Tumor size (cm)
≤ 5	105 (36.5)
5 < size ≤ 10	125 (43.4)
> 10	58 (20.1)
Child-Pugh score
A	260 (90.3)
B	28 (9.7)
AFP (ng/mL)
≤ 200	161 (57.7)
> 200	118 (42.3)

HBV: Hepatitis B virus; TNM: Tumor-node-metastasis; AFP: Alpha-fetoprotein.

Table 2 Analysis of factors affecting survival

	Death/all cases	Median survival time (95%CI)	P value
Age (yr)			0.612
≤ 60	165/208	19 (13.470-24.530)
> 60	63/80	23 (15.988-30.012)
Gender			0.605
Male	36/49	20 (6.283-33.717)
Female	193/239	20 (15.131-24.869)
Tumor size (cm)			< 0.001
≤ 5	67/105	34 (17.568-50.432)
5 < size ≤ 10	107/125	17 (8.965-25.035)
> 10	55/58	8 (4.890-11.110)
Tumor status			< 0.001
T1	90/126	33 (24.933-41.067)
T2	14/22	25 (0.000-73.264)
T3a	26/31	15 (5.184-24.816)
T3b	24/27	8 (5.470-10.530)
T4	75/82	12 (7.905-16.095)
Regional lymph node metastasis			< 0.001
No	205/264	22 (16.882-27.118)
Yes	24/24	8 (3.999-12.001)
Distant metastasis			< 0.001
No	217/276	22 (17.691-26.309)
Yes	12/12	4 (2.303-5.697)
Child-Pugh score			< 0.001
A	203/260	23 (18.485-27.515)
B	26/28	7 (2.851-11.149)
AFP (ng/mL)			< 0.001
≤ 200	118/161	28 (21.162-34.838)
> 200	102/118	12 (8.198-15.802)
Expansive growth and invasive growth			< 0.001
Single tumor	103/143	33 (24.408-41.592)
Multiple tumors	18/25	25 (8.680-41.320)
Satellite nodules (including perforation tumor encapsulation)	18/22	13 (10.242-15.758)
Nodules fusion (including diffuse growth which lack tumor encapsulation)	16/18	12 (3.684-20.316)
Direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum	74/80	12 (7.956-16.044)
Disseminative growth			< 0.001
Without vascular or regional lymph node involvement	155/210	28 (21.928-34.072)
Vascular involvement	42/46	8 (4.979-11.021)
Regional lymph node involvement	21/21	10 (4.019-15.981)
Distant metastasis	12/12	4 (2.303-5.697)
EID stage			< 0.001
I	96/140	36 (27.626-44.374)
II	84/99	16 (11.450-20.550)
III	38/38	8 (4.375-11.625)
IV	11/11	5 (3.436-6.564)
TNM stage			< 0.001
I	84/119	35 (26.448-43.552)
II	14/22	25 (0.000-73.264)
IIIA	19/24	16 (2.557-29.443)
IIIB	22/25	8 (1.880-14.120)
IIIC	58/66	15 (10.033-19.967)
IVA	21/21	10 (4.019-15.981)
IVB	11/11	5 (3.436-6.564)

AFP: Alpha-fetoprotein; EID: Expansive-Invasive-Disseminative growth; TNM: Tumor-node-metastasis.

Table 3 Expansive-Invasive-Disseminative growth staging classification

Phase	Growth characteristics
I	Expansive tumor growth (single tumor and multiple tumors)
II	Expansive tumor growth along with vascular and/or regional lymph node involvement
	Invasive tumor growth (satellite nodules, nodule fusion and tumor direct invasion of adjacent organs)
III	Invasive tumor growth along with vascular/regional lymph node involvement
IV	Distant metastasis of tumor

Table 4 Characteristics of patients as defined by Expansive-Invasive-Disseminative growth stage n (%)

Characteristics	I	II	III	IV
Age (yr)
≤ 60	96 (68.6)	78 (78.8)	26 (68.4)	8 (72.9)
> 60	44 (31.4)	21 (21.2)	12 (31.6)	3 (27.3)
Gender
Female	27 (19.3)	15 (15.2)	5 (13.2)	2 (18.2)
Male	113 (80.7)	84 (84.8)	33 (86.8)	9 (81.8)
HBV infection	105 (75.0)	75 (75.8)	23 (60.5)	8 (72.7)
TNM stage
I	117 (83.6)	2 (2.0)	0	0
II	12 (8.6)	10 (10.1)	0	0
IIIA	9 (6.4)	15 (15.2)	0	0
IIIB	0	20 (20.2)	5 (13.2)	0
IIIC	2 (1.4)	46 (44.5)	18 (47.4)	0
IVA	0	6 (6.1)	15 (39.5)	0
IVB	0	0	0	11 (100)
Tumor size (cm)
≤ 5	71 (50.7)	27 (27.3)	5 (13.2)	2 (18.2)
5 < size ≤ 10	52 (37.1)	50 (50.5)	18 (47.4)	5 (45.5)
> 10	17 (12.1)	22 (22.2)	15 (39.5)	4 (36.4)
Child-Pugh score
A	128 (91.4)	92 (92.9)	30 (78.9)	10 (90.9)
B	12 (8.6)	7 (7.1)	8 (21.1)	1 (9.1)
AFP (ng/mL)
≤ 200	91 (66.4)	46 (47.4)	20 (55.6)	4 (44.4)
> 200	46 (33.6)	51 (52.6)	16 (44.4)	5 (55.6)

HBV: Hepatitis B virus; TNM: Tumor-node-metastasis; AFP: Alpha-fetoprotein.

Citation: Zhu CH, Liu XH, Cao R, Wu XZ. Proposal of new classification for postoperative patients with hepatocellular carcinoma based on tumor growth characteristics. World J Gastroenterol 2013; 19(33): 5534-5541
URL: https://www.wjgnet.com/1007-9327/full/v19/i33/5534.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i33.5534